Rare Side Effects After Inactiveted Sars-Cov-2 Vaccine (Coronavac)

T. S. Tat, V. Boşnak, Gulşah Baycelebi
{"title":"Rare Side Effects After Inactiveted Sars-Cov-2 Vaccine (Coronavac)","authors":"T. S. Tat, V. Boşnak, Gulşah Baycelebi","doi":"10.18521/ktd.1061482","DOIUrl":null,"url":null,"abstract":"Objective: To evaluate the frequency, type, onset time, and intensity of the side effects after the Coronavac vaccination in healthcare workers (HCW) and elderly people and also to determine whether COVID-19 disease occurs after vaccination in HCW. Methods: HCW and elderly people who were vaccinated in Gaziantep Medical Park were the cohorts of the study. A questionnaire was applied to HCW, and the data of elderly people were obtained from medical records. The questionnaire had demographic data, medical history also included COVID-19-related and side effects of the Coronavac vaccine. Results: Four hundred twenty-seven questionnaires were analyzed. The most common adverse reaction was pain at the injection site. The incidences of pain after the first and second injections were 23.8% (102/427) and 12.8% (52/405), respectively. And most common systemic side effect was fatigue with an incidence of 18.2% and 10.3% after each dose, respectively. Side effects that kept HCW from going to work after vaccination were not observed. After the two doses of vaccination, only 7 HCW had mild COVID-19 infection. One had a COVID-19 infection after 7 days of the first dose. 354 medical records of elderly people were evaluated. Only one of them reported urticaria after the first dose. Conclusions: Our study found that Coronavac is a well-tolerated and effective vaccine.","PeriodicalId":174708,"journal":{"name":"Konuralp Tıp Dergisi","volume":"6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Konuralp Tıp Dergisi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18521/ktd.1061482","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Objective: To evaluate the frequency, type, onset time, and intensity of the side effects after the Coronavac vaccination in healthcare workers (HCW) and elderly people and also to determine whether COVID-19 disease occurs after vaccination in HCW. Methods: HCW and elderly people who were vaccinated in Gaziantep Medical Park were the cohorts of the study. A questionnaire was applied to HCW, and the data of elderly people were obtained from medical records. The questionnaire had demographic data, medical history also included COVID-19-related and side effects of the Coronavac vaccine. Results: Four hundred twenty-seven questionnaires were analyzed. The most common adverse reaction was pain at the injection site. The incidences of pain after the first and second injections were 23.8% (102/427) and 12.8% (52/405), respectively. And most common systemic side effect was fatigue with an incidence of 18.2% and 10.3% after each dose, respectively. Side effects that kept HCW from going to work after vaccination were not observed. After the two doses of vaccination, only 7 HCW had mild COVID-19 infection. One had a COVID-19 infection after 7 days of the first dose. 354 medical records of elderly people were evaluated. Only one of them reported urticaria after the first dose. Conclusions: Our study found that Coronavac is a well-tolerated and effective vaccine.
Sars-Cov-2灭活疫苗(Coronavac)的罕见副作用
目的:评价医护人员和老年人接种冠状病毒疫苗后不良反应的频次、类型、发生时间和强度,确定医护人员接种后是否发生COVID-19疾病。方法:以在加济安泰普医疗公园接种疫苗的HCW和老年人为研究对象。HCW采用问卷调查,老年人的数据来源于病历。问卷中有人口统计数据,病史还包括冠状病毒疫苗的相关和副作用。结果:共分析问卷427份。最常见的不良反应是注射部位疼痛。第一次和第二次注射后疼痛发生率分别为23.8%(102/427)和12.8%(52/405)。最常见的全身副作用是疲劳,每次给药后的发生率分别为18.2%和10.3%。未观察到疫苗接种后HCW无法发挥作用的副作用。两剂疫苗接种后,只有7名HCW出现了轻度感染。其中一人在第一次注射7天后感染了COVID-19。对354例老年人病历进行评价。其中只有一人在第一次注射后出现荨麻疹。结论:我们的研究发现Coronavac是一种耐受性良好且有效的疫苗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信